Human normal immunoglobulin (Additional dosage) -- Adults and Children
Drug information
Section 11: Blood products and plasma substitutes 11.2: Plasma fractions for specific use
Formulation:
Subcutaneous administration: 20% protein solution
Application prepared by:
CSL Behring AG
-
Application for inclusion of Polyvalent Human Immunoglobulins 20%
pdf, 358kb - EXPERT REVIEWS
-
Support from the International Patient Organisation for Primary Immunodeficiencies (IPOPI)
pdf, 113kb -
Support from the Latin American Society for Immunodeficiencies (LASID)
pdf, 651kb -
Support from the African Society for Immunodeficiencies (ASID)
pdf, 268kb -
Memorandum from Coordinator, QSM
pdf, 484kb